TransMedics Group Inc (TMDX)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	261,881	237,792	217,609	185,189	154,093	126,872	104,325	81,934	65,272	51,555	37,213	28,452	21,159	19,001	20,266	16,586	16,635	15,548	14,726	16,150
Revenue (ttm)	US$ in thousands	441,540	401,090	358,759	296,919	241,623	191,824	151,077	119,133	93,459	71,752	51,439	39,089	30,262	28,221	29,942	25,162	25,639	24,069	24,183	26,458
Gross profit margin		59.31%	59.29%	60.66%	62.37%	63.77%	66.14%	69.05%	68.78%	69.84%	71.85%	72.34%	72.79%	69.92%	67.33%	67.68%	65.92%	64.88%	64.60%	60.89%	61.04%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $261,881K ÷ $441,540K
= 59.31%

TransMedics Group Inc's gross profit margin has shown fluctuations over the analyzed periods, ranging from a low of 59.29% on September 30, 2024, to a high of 72.79% on March 31, 2022. The trend generally indicates an increasing pattern from late 2020 to early 2022, with the margin peaking in December 2021. However, there has been a decline in the margin since then, with a notable decrease in the last few quarters of 2024. Despite the recent downward trend, the company has maintained its gross profit margin above 60% for the most part, reflecting healthy profitability in its operations. The management may need to monitor cost structures and pricing strategies to sustain or enhance the gross profit margin in the future.